Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients
Jung Eun Lee, Hyung Jong Kim, Sung Jin Moon, Ji Sun Nam, Jwa-Kyung Kim, Seung Kyu Kim, Gi Young Yun, Sung Kyu Ha, Hyeong Cheon Park
Korean J Intern Med. 2013;28(6):668-677. Published online 2013 Oct 29 DOI: https://doi.org/10.3904/kjim.2013.28.6.668
Citations to this article as recorded by 
Vascular calcification inhibitors and cardiovascular events in peritoneal dialysis patients
Refik Olmaz, Tamer Selen, Ozkan Gungor
Therapeutic Apheresis and Dialysis.2024; 28(2): 169. CrossRef
Association of the Serum Osteoprotegerin Level With Target Organ Damage in Patients at High Risk of Coronary Artery Disease
Jaehoon Chung, Hack-Lyoung Kim, Jung Pyo Lee, Woo-Hyun Lim, Jae-Bin Seo, Sang-Hyun Kim, Joo-Hee Zo, Myung-A Kim
Circulation Journal.2020; 85(1): 69. CrossRef
Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid–femoral pulse wave velocity in hemodialysis patients: a cross sectional study
Jia-Sian Hou, Yu-Li Lin, Chih-Hsien Wang, Yu-Hsien Lai, Chiu-Huang Kuo, Yi-Maun Subeq, Bang-Gee Hsu
BMC Nephrology.2019;[Epub] CrossRef
Role of vascular calcification inhibitors in preventing vascular dysfunction and mortality in hemodialysis patients
Ozkan Gungor, Ismail Kocyigit, Mahmut Ilker Yilmaz, Siren Sezer
Seminars in Dialysis.2018; 31(1): 72. CrossRef
The Correlation of Serum Osteoprotegerin with Non-Traditional Cardiovascular Risk Factors and Arterial Stiffness in Patients with Pre-Dialysis Chronic Kidney Disease: Results from the KNOW-CKD Study
Seung Yun Chae, WooKyung Chung, Yeong Hoon Kim, Yun Kyu Oh, Joongyub Lee, Kyu Hun Choi, Curie Ahn, Yong-Soo Kim
Journal of Korean Medical Science.2018;[Epub] CrossRef
Does the OPG/RANKL system contribute to the bone-vascular axis in chronic kidney disease? A systematic review
Beata Znorko, Ewa Oksztulska-Kolanek, Małgorzata Michałowska, Tomasz Kamiński, Krystyna Pawlak
Advances in Medical Sciences.2017; 62(1): 52. CrossRef
Osteoprotegerin and uremic osteoporosis in chronic hemodialysis patients
Diana Moldovan, Crina Rusu, Alina Potra, Ioan Moldovan, Ioan Mihai Patiu, Mirela Gherman-Caprioara, Ina Maria Kacso
International Urology and Nephrology.2017; 49(5): 895. CrossRef
Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function
Sílvia Collado, Elisabeth Coll, Carlos Nicolau, Manel Azqueta, Mercedes Pons, Josep M Cruzado, Bernat de la Torre, Ramón Deulofeu, Sergi Mojal, Julio Pascual, Aleix Cases
BMC Nephrology.2017;[Epub] CrossRef
MMP-2 serum concentrations predict mortality in hemodialysis patients: a 5-year cohort study
Kuang-Chih Hsiao, Jen-Pi Tsai, Shun-Fa Yang, Wen-Chin Lee, Jong-Yu Huang, Shun-Chi Chang, Chun-Shuo Hso, Horng-Rong Chang
Clinica Chimica Acta.2016; 452: 161. CrossRef
Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis
Gernot Pichler, Maria C. Haller, Alexander Kainz, Myles Wolf, Josep Redon, Rainer Oberbauer
Nephrology Dialysis Transplantation.2016; : gfw387. CrossRef
Vascular Calcification Scores are Associated with Arterial Stiffness, Inflammation, and Nutrition in Hemodialysis Patients
Sun Young Shin, Kyu Hyun Han, Hye Yun Jeong, Ji Min Chu, Hong-Min Kim, Seongeun Suh, Yukyung Hyun, Hyung-Jong Kim
Korean Journal of Medicine.2014; 87(1): 42. CrossRef
ARTERIJŲ STANDUMAS: SĄSAJOS SU LĖTINE INKSTŲ LIGA
Agnė Laučytė Cibulskienė, Marius Miglinas
Medicinos teorija ir praktika.2014; 20(3): 213. CrossRef
A biomarker, osteoprotegerin, in patients undergoing hemodialysis
Gang Jee Ko
The Korean Journal of Internal Medicine.2013; 28(6): 654. CrossRef